Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston
Who Went to Discovery on Target 2026
Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website
510 organizations and 294 speakers at Discovery on Target 2026, a ~1,100-person, mostly biopharma meeting of target discovery biologists and medicinal chemists. As of Oct 8, 2026.
| Organization | Discovery on Target 2026 Attendance |
|---|---|
Pfizer New York, NY | |
Global pharmaceutical company developing medicines and vaccines in oncology, inflammation and immunology, internal medicine and rare diseases. | Chair Tue Sep 29 1:45pm–1:50pm Talk Tue Sep 29 2:20pm–2:50pm Panel Tue Sep 29 5:00pm–6:00pm Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach Novel drug modalitiesInnovative discovery technologies Panel Wed Sep 30 7:30am–8:15am Talk Wed Sep 30 11:50am–12:20pm Chair Wed Sep 30 2:00pm–2:05pm Talk Wed Sep 30 2:35pm–3:05pm Panel Thu Oct 1 7:30am–8:15am Talk Thu Oct 1 9:35am–10:05am Talk Thu Oct 1 3:30pm–4:00pm |
AstraZeneca Cambridge, UK | |
Global biopharmaceutical company with medicines in oncology, cardiovascular, respiratory, immunology and rare diseases. | Chair Mon Sep 28 1:30pm–1:35pm Panel Tue Sep 29 11:05am–12:05pm Talk Tue Sep 29 1:50pm–2:20pm Talk Tue Sep 29 2:50pm–3:20pm Panel Tue Sep 29 5:00pm–6:00pm Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach Novel drug modalitiesInnovative discovery technologies Talk Wed Sep 30 9:05am–9:35am Talk Wed Sep 30 2:05pm–2:35pm Panel Wed Sep 30 3:05pm–4:05pm Panel Thu Oct 1 7:30am–8:15am |
Genentech South San Francisco, CA | |
Biotechnology company and member of the Roche Group, discovering and developing medicines in oncology, immunology and neuroscience. | Talk Mon Sep 28 10:15am–10:45am Talk Tue Sep 29 11:05am–11:35am Talk Wed Sep 30 12:20pm–12:50pm Talk Wed Sep 30 2:05pm–2:35pm Talk Thu Oct 1 11:50am–12:20pm Talk Thu Oct 1 4:05pm–4:35pm Talk Thu Oct 1 4:35pm–5:05pm |
University of California, San Francisco San Francisco, CA | |
Panel Mon Sep 28 5:00pm–6:00pm Talk Tue Sep 29 10:35am–11:35am Talk Tue Sep 29 11:35am–12:05pm Talk Wed Sep 30 11:50am–12:20pm Talk Wed Sep 30 12:20pm–12:50pm Talk Thu Oct 1 10:05am–10:35am Talk Thu Oct 1 10:35am–11:05am | |
Novartis Basel, Switzerland | |
Global pharmaceutical company; Novartis Biomedical Research is its drug discovery arm. | Panel Mon Sep 28 10:45am–11:30am Talk Tue Sep 29 2:20pm–2:50pm Panel Tue Sep 29 5:00pm–6:00pm Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach Novel drug modalitiesInnovative discovery technologies Talk Wed Sep 30 2:05pm–2:35pm Panel Thu Oct 1 7:30am–8:15am |
Bristol Myers Squibb Princeton, NJ | |
Global biopharmaceutical company with medicines in oncology, immunology, cardiovascular disease and neuroscience. | Talk Tue Sep 29 8:35am–9:05am Panel Tue Sep 29 5:00pm–6:00pm Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach Novel drug modalitiesInnovative discovery technologies Panel Wed Sep 30 7:30am–8:15am Talk Thu Oct 1 12:20pm–12:50pm Talk Thu Oct 1 3:35pm–4:05pm |
Instantly find 20 buyers from companies at Discovery on Target 2026
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
When and where was Discovery on Target 2026?
Discovery on Target 2026 ran September 28 – October 1, 2026, at the Sheraton Boston Hotel in Boston, MA.
What conference is this?
Discovery on Target is an annual drug discovery meeting, held September 28 – October 1, 2026 at the Sheraton Boston Hotel. It brings together target biologists, medicinal chemists and discovery leaders from pharma, biotech and academia with the CROs, chemistry, screening, reagent, instrument and software companies that serve them, across programs on emerging targets, novel modalities, lead generation, discovery technologies, induced proximity, antibodies against challenging targets, conjugates, radioligand therapies and AI-driven drug design. The meeting has ended; this guide is its record.
What is in this guide?
Every organization we can place at Discovery on Target 2026: 294 speakers from the public agenda (305 talks, panels, roundtables and sponsored presentations) rolled up to their companies and institutions, the 67 exhibitors from the floor plan with their booth numbers, 58 sponsors with their level, and the 506 companies on the attendee list the organizers published — 510 organizations in one list. Speakers appear as job titles, never by name, and nothing about an individual attendee is shown.
How are organizations typed?
By the role an organization plays in drug discovery: drug developers (large pharma and biotech), then the companies around them — CROs and CDMOs, instrument and lab automation makers, reagent, assay and model-system suppliers, software and AI companies, and consultancies and other services — and academic, government and non-profit bodies. The topic filters come from the program a talk sits in.
How current is it?
Pulled from the public program agendas, floor plan, sponsor page and attendee list on October 8, 2026, a week after the meeting closed. Exhibit hall hours are from the organizer’s exhibit schedule.
Browse Discovery on Target 2026 by
Organizations with their own page
157 organizations — every exhibitor and every organization with 2 or more presentations.
- Abalone Bio
- AbbVie
- AbTx
- Actithera
- Adimab
- Ajinomoto Bio-Pharma Services
- Alipheron
- AmberGen
- Amgen
- Apeloa Pharma Solutions
- Aptamer Group
- Aragen
- argenx
- AstraZeneca
- Asymchem
- Atombeat
- Aureka Biotechnologies
- Aurigene Pharmaceutical Services
- Avacta Therapeutics
- Barcelona Supercomputing Center
- Baylor College of Medicine
- BenchSci
- Binghamton University
- Biogen
- Biosensing Instrument
- Birdwood Therapeutics
- BPS Bioscience
- Brigham and Women's Hospital
- Bristol Myers Squibb
- Broad Institute
- Carterra
- CAS
- Certara
- Chapman University
- Collaborative Drug Discovery
- Concept Life Sciences
- Conigen Bioscience
- Consensus
- Cube Biotech
- Cullgen
- Dana-Farber Cancer Institute
- Deep EigenMatics
- Dewpoint Therapeutics
- DIMA Biotech
- Domainex
- Drug Hunter
- Dyne Therapeutics
- Eli Lilly
- EMD Serono
- Enamine
- Eurofins Discovery
- Fidabio
- Foghorn Therapeutics
- Fovus
- Fox Chase Cancer Center
- Frontier Medicines
- GBI Biomanufacturing
- Genentech
- Generate Biomedicines
- Ginkgo Bioworks
- GSK
- Harvard Medical School
- Herbert Wertheim UF Scripps Institute
- HitChem
- HitGen
- Imperial College London
- Inductive Bio
- InduPro
- Insilico Medicine
- Institute for Protein Innovation
- Johns Hopkins University
- Johnson & Johnson
- Jubilant Biosys
- KACTUS
- Kainova Therapeutics
- Kairos Pharma
- Kiral Medicines
- LenioBio
- LifeSensors
- Lightcast Discovery
- lino Biotech
- LiteFold
- Lumina Pharmaceuticals
- Mariana Oncology
- Massachusetts Institute of Technology
- Mcule
- MedChemExpress
- Model Medicines
- Molox
- MolPort
- Montai Therapeutics
- National Institutes of Health
- NMX Research and Solutions
- Normunity
- Novartis
- Nuclera
- Nuclide Therapeutics
- o2h discovery
- Ohio State University
- Open Molecular Software Foundation
- OpenEye, Cadence Molecular Sciences
- OpenFold
- ORIA Bioscience
- PAIA Biotech
- Perceptive
- Perspective Therapeutics
- Pfizer
- PharmaBlock
- PharmaResources
- Pharmaron
- Piramal Pharma Solutions
- Portal Biotechnologies
- PozeSCAF
- Prelude Therapeutics
- Progenra
- Promega
- Protagonist Therapeutics
- PsiThera
- RAMP
- Receptor.AI
- RedShiftBio
- Remix Therapeutics
- Revolution Medicines
- Richman Chemical
- Sanofi
- Simulations Plus
- Sino Biological
- Stanford University
- STEMCELL Technologies
- Sygnature Discovery
- Syngene
- Tagworks Pharmaceuticals
- Tahoe Therapeutics
- TargetMol
- The Institute of Cancer Research
- TICRO Bioservices
- Trilogie Bioscience
- TRIMTECH Therapeutics
- TrueCourse Biosciences
- TubeWriter
- UCB
- Unchained Labs
- University of California, San Francisco
- University of Liverpool
- University of Michigan
- University of Minnesota
- University of Pennsylvania
- University of Texas at Austin
- University of Wisconsin–Madison
- Uppsala University
- Vaccinex
- Vazyme
- VelaVigo
- WuXi AppTec
- X-Chem
- XtalPi
- Yale University
Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction